Catalysts
PTCT Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
PTCT
CatalystsStock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 33/100 and sentiment — before the next covered event.
Updated Sep 6, 2026 · Sentiment 42.79%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | — | $0.24 | $0.92 | +289.3% | $298.63M | $360.52M |
| May 7, 2026 | — | -$0.45 | -$0.03 | +93.3% | $217.42M | $272.55M |
| Feb 19, 2026 | — | -$0.21 | -$1.67 | -695.2% | $279.48M | $164.68M |
| Nov 4, 2025 | — | -$1.19 | $0.20 | +116.8% | $281.45M | $211.01M |
| Aug 7, 2025 | — | -$1.07 | -$0.83 | +22.4% | $191.46M | $178.88M |
| May 6, 2025 | — | -$1.08 | $10.04 | +1029.6% | $372.61M | $1.18B |
| Feb 27, 2025 | — | -$1.12 | -$0.85 | +24.1% | $232.44M | $213.17M |
| Nov 7, 2024 | — | -$1.54 | -$1.39 | +9.7% | $190.47M | $196.79M |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
PTC Therapeutics, Inc. (PTCT) Discusses Acquisition of ST-920 Fabry Gene Therapy Asset and Clinical Data from STAAR Study Transcript
PTC Therapeutics, Inc. (PTCT) Discusses Acquisition of ST-920 Fabry Gene Therapy Asset and Clinical Data from STAAR Study August 12, 2026 5:00 PM EDTCompany...
Related Links
PTCT Catalysts FAQ
What are the next catalysts for PTCT stock?
PTCT's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move PTCT stock?
Upcoming events that could move PTCT include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could PTCT's next earnings report affect the stock?
PTCT's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive PTCT stock higher?
PTCT could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt PTCT stock?
PTCT could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.